National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa

MEM-VAB seems effective as a salvage treatment in compassionate use, but vaborbactam was shown to lack benefits compared to meropenem in treating <i>P. aeruginosa</i>-related infections. Therefore, it is crucial to compare meropenem to MEM-VAB MICs, particularly for <i>P. aeruginosa</i>, before prescribing MEM-VAB.

Authors

Institutions

Publication Details

Journal
Antibiotics
Published
2024-12-01
DOI
https://doi.org/10.3390/antibiotics13121152
Citations
1
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa

Anaïs Potron, Frédérique Bouchand, Aurélien Dinh, David Boutoille et al.
1 citations
Antibiotics
Antibiotic Resistance in Bacteria
0.17
article

National Cohort of Compassionate Use of Meropenem–Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa

Anaïs Potron, Frédérique Bouchand, Aurélien Dinh, David Boutoille, Éric Senneville, Stéphane Corvec, Laurent Dortet, Clara Duran, H. Wille, Jullien Crozon-Clauzel, Patricia Pavèse, E. Fiaux, Alexandre Bleibtreu, Katy Jeannot, Mariam Roncato-Sabéran, Morgan Matt, Marie Lacoste, C. Thumerelle, A. Boibieux, Annlyse Fanton, Benoît Pilmis, Fanny Vuotto, Alexie Bosch, Quentin Saint-Genis
article en
1 citations

Abstract

MEM-VAB seems effective as a salvage treatment in compassionate use, but vaborbactam was shown to lack benefits compared to meropenem in treating <i>P. aeruginosa</i>-related infections. Therefore, it is crucial to compare meropenem to MEM-VAB MICs, particularly for <i>P. aeruginosa</i>, before prescribing MEM-VAB.

AntibioticsVol. 13(12)
Inserm (FR), Université Paris Cité (FR), Université de Lille (FR), Université Paris-Saclay (FR), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Assistance Publique – Hôpitaux de Paris (FR), Centre Hospitalier Métropole Savoie (FR), Centre Hospitalier de Tourcoing (FR), Polyclinique Bordeaux Nord Aquitaine (FR), Hôpital Saint Joseph (FR), Pitié-Salpêtrière Hospital (FR), Centre Hospitalier de la Côte Basque (FR), Centre d'Investigation Clinique de Nantes (FR), CNR de la Résistance aux Antibiotiques (FR), Hôpital Raymond-Poincaré (FR), Centre Hospitalier de La Rochelle (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Bicêtre Hospital (FR), Université de Rouen Normandie (FR), Université Grenoble Alpes (FR), Nantes Université (FR)
Good health and well-being
Openalex Percentile: Top 54%
Antibiotic Resistance in Bacteria
0.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.